E-Pharmacy Market, By Drug Class (OTC Drugs, and Prescription Drugs), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI3518 | Publish Date: April 2024 | No. of Pages: 180

Global EPharmacy Market By Drug Overview

Introduction:

E-Pharmacy Market was valued at US$ 85 billion in 2024 and is projected to grow at a CAGR of 21.0% to reach US$ 574 billion by 2034.

E-Pharmacy is web-based supplier of medicine which offers various benefits over premise-based retail pharmacy store. E-pharmacy platform provides all types of pharmaceutical drugs such as prescription products, OTC drugs, and personal care products to its customers. Where the customers just need to upload the prescription on the internet and the drugs are delivered at the doorstep of the customer. 

E-Pharmacy Market - Introduction

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global EPharmacy Market By Drug Dynamics

The significant factor to drive the growth of the E-Pharmacy market is increasing penetration of internet and smart phones across the world. Due to which the consumers are shifting towards online based stores in almost all commodity. Further, ease in connectivity, consumers can demand the medicines without visiting any physical location, and can receive medicines and other articles in quickest time. In addition they could get counselling service and other important medical information about product they wish to order over phone.

Further, global increase in the geriatric population pool is steadily increasing. According to report by United Nation in 2017, global population above 60 is increasing at rate of 3% each year; it would reach 1.3Bn by 2025. However, aging population living alone often find it difficult to timely visit the retail pharmacy, and they also fail to memorize order due to  age related dementia, Online pharmacy could provide solution to this with automated reminder about medicines order and other information.

However easy availability of drug through E-Pharmacy channel has led to incidence of adverse drug reaction due to analgesics, anxiolytics, anti-psychotics, opioids, and cough syrup etc. Therefore, most of national government are being cautious before granting rights to E-Pharmacy and strictly regulating the business which may lead to deterrence to market growth of the E-Pharmacy market.

Global EPharmacy Market By Drug Segmentation

The E-Pharmacy market has been segmented on the basis of drug class and region.

On the basis of drug class the E-pharmacy market has been segmented into OTC drugs and prescription drugs.

Regional Insights:

E-Pharmacy Market - Regional Insights

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

E-Pharmacy Market Regional Insights

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account major market share as compared to that of other regions.

Report scope:

Attribute

Details

Market Size 2024

US$ 85.0 Billion

Projected Market Size 2034

US$ 574.0 Billion

CAGR Growth Rate

21.0%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 to 2034

Market Segmentation

By Drug Class - OTC Drugs, and Prescription Drugs

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

 

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the E-Pharmacy Market report based on drug class and region:

E-Pharmacy Market, By Drug Class

  • OTC Drugs
  • Prescription Drugs

E-Pharmacy Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global EPharmacy Market By Drug Key Players

Key players operating in the E-Pharmacy Market include The Kroger Co., Walgreen Co., Wal-Mart Stores, Inc., CVS Health,Express Scripts Holding Company, Giant Eagle, Inc., DocMorris Rowlands Pharmacy, and OptumRx, Inc.

Global EPharmacy Market By Drug Key Issues Addressed

Recent Development:

  • In November 2023, Vice President of Ghana, Dr Mahamudu Bawumia officially launched the National Electronic Pharmacy Platform (NEPP). The NEPP is the first national-scale e-Pharmacy platform in Africa, and one of the few in the world. It is a digital convergence of licensed pharmacies across the country, which enables Ghanaians to have access to prescribed medicines and buy them by making an order with a mobile phone through the e-Pharmacy app, website, or a shortcode, and have the medicine delivered to a requested location.

Global EPharmacy Market By Drug Company Profile

  • The Kroger Co.*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Walgreen Co.
  • Wal-Mart Stores, Inc.
  • CVS Health
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • DocMorris Rowlands Pharmacy
  • OptumRx, Inc.

“*” marked represents similar segmentation in other categories in the respective section

Global EPharmacy Market By Drug Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Class
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Drug Class , Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • OTC Drugs
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Prescription Drugs
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Drug Class , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Drug Class , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Drug Class , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Drug Class , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Drug Class , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  2. Company Profiles
  • The Kroger Co.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Walgreen Co.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Wal-Mart Stores, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • CVS Health
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Express Scripts Holding Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Giant Eagle, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • DocMorris Rowlands Pharmacy
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • OptumRx, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

E-Pharmacy Market is segmented, By Drug Class (OTC Drugs, and Prescription Drugs).

The significant factor to drive the growth of the E-Pharmacy market is increasing penetration of internet and smart phones across the world.

Key players operating in the E-Pharamacy market include The Kroger Co., Walgreen Co., Wal-Mart Stores, Inc., CVS Health,Express Scripts Holding Company, Giant Eagle, Inc., DocMorris Rowlands Pharmacy, and OptumRx, Inc.